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ABSTRACT
WhiB1 is a monomeric iron–sulfur cluster-containing
transcription factor in the WhiB-like family that is
widely distributed in actinobacteria including the no-
toriously persistent pathogen Mycobacterium tuber-
culosis (M. tuberculosis). WhiB1 plays multiple roles
in regulating cell growth and responding to nitric ox-
ide stress in M. tuberculosis, but its underlying mech-
anism is unclear. Here we report a 1.85 A˚-resolution
crystal structure of the [4Fe–4S] cluster-bound (holo-
) WhiB1 in complex with the C-terminal domain of the
70-family primary sigma factor A of M. tuberculo-
sis containing the conserved region 4 (A4). Region
4 of the 70-family primary sigma factors is com-
monly used by transcription factors for gene acti-
vation, and holo-WhiB1 has been proposed to acti-
vate gene expression via binding toA4. The complex
structure, however, unexpectedly reveals that the in-
teraction between WhiB1 and A4 is dominated by
hydrophobic residues in the [4Fe–4S] cluster bind-
ing pocket, distinct from previously characterized
canonical 704-bound transcription activators. Fur-
thermore, we show that holo-WhiB1 represses tran-
scription by interaction with A4 in vitro and that
WhiB1 must interact with A4 to perform its essential
role in supporting cell growth in vivo. Together, these
results demonstrate that holo-WhiB1 regulates gene
expression by a non-canonical mechanism relative to
well-characterized A4-dependent transcription acti-
vators.
INTRODUCTION
Mycobacterium tuberculosis is the main causative pathogen
of tuberculosis and the second greatest killer after the Hu-
man Immunodeficiency Virus (HIV) among single infec-
tious agents (1).M. tuberculosis causes disease by adapting
to the host immune response using dedicated regulatory sys-
tems that include the White B-like (Wbl) family proteins.
Wbl proteins contain a [4Fe–4S] cluster, were first identi-
fied in Streptomyces coelicolor, and are widely distributed
in actinobacteria (2,3). Seven Wbl proteins are found inM.
tuberculosis, and they play versatile roles in diverse biologi-
cal processes including redox homeostasis, cell division, nu-
trition starvation and antibiotic resistance (4–6).
Structural and functional analyses indicate that M. tu-
berculosis Wbl proteins are monomeric transcription fac-
tors with three conserved motifs (4): (i) a [4Fe–4S] cluster
bindingmotif consisting of four cysteines in theN-terminus,
(ii) a DNA binding motif (also known as AT-hook) in the
C-terminus and (iii) an intervening Gly-rich motif (-turn)
that links the two functional domains.M. tuberculosisWbl
proteins interact with the primary sigma factor A of the
RNA polymerase (RNAP) holoenzyme in their [4Fe–4S]
cluster-bound (holo-) form, but not in their cluster-free
(apo-) form (7,8). A is a member of the 70-family primary
sigma factors possessing four conserved regions (region 1–
4), of which region 4 (704) recognizes the −35 element and
is a highly conserved hub for direct interaction with many
transcription factors including theM. tuberculosisWbl pro-
teins (7,9,10). TwoWbl members (WhiB3 andWhiB7) have
been shown to require interaction with A4 to activate tran-
scription (7,11,12).
Among the M. tuberculosis Wbl proteins, WhiB1 is of
particular interest because it is essential for cell growth and
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it is suggested to have a role in the initiation of dormancy
in response to nitric oxide (NO) (6). NO is a potent antimi-
crobial chemical produced by hosts to combat tuberculosis
infection (13,14). Consequently, the transcription factors in
the defense system ofM. tuberculosis that swiftly sense and
respond to NO are critical for the survival and pathogenesis
of the bacterium. The [4Fe–4S] cluster inWhiB1 is highly re-
active toNOoverO2 (15,16), making it a specificNO sensor
in aerobic bacteria. NOdisrupts theWhiB1 [4Fe–4S] cluster
by initially forming a [Fe-S] cluster–NO complex, and even-
tually resulting in cluster degradation and formation of apo-
WhiB1 (15). Binding ofWhiB1 to A significantly decreases
the O2 reactivity of the [4Fe–4S] cluster in the WhiB1:A
complex, which is reportedly stable under aerobic condi-
tions for two weeks while retaining high reactivity to NO
(8). Upon exposure to NO both in vitro and in Escherichia
coli, the WhiB1:A complex was observed to rapidly react
with NO and disassociate (8). This observation indicates a
potential role of WhiB1 as a NO sensor and regulator in
mycobacteria considering that theWhiB1:A complex is re-
active to NO in the presence of the native NO-sensing and
detoxification system in E. coli (17). The molecular basis
for the O2 stability of the [4Fe–4S] cluster in the WhiB1:A
complex is unknown because the structure of the complex
has not been determined.
Both NO-treated holo-WhiB1 and apo-WhiB1, but not
holo-WhiB1, have been shown to bind to and repress at
least two essential genes: groEL2, encoding a chaperonin;
and whiB1 itself (6,18). The positively charged residues in
the C-terminal DNA binding motif of apo-WhiB1, includ-
ing Lys72, Arg73, Arg74, Lys79 and Arg81, are required for
DNA binding (19). For this reason, WhiB1 was defined as
a transcriptional repressor in the past (6), while the active
form of WhiB1 that supports active mycobacterial growth
remains elusive. Based on its interaction with A4, holo-
WhiB1 has been proposed to activate gene expression us-
ing a canonical mechanism utilized by Class II transcrip-
tion activators such as the cyclic AMP receptor protein
(CRP) and the fumarate and nitrate reduction regulatory
protein (FNR) (10,20–24). However, holo-WhiB1 possesses
characteristics that are different from previously charac-
terized Class II transcription activators. First, WhiB1 is a
monomeric transcription factor with a single DNA binding
motif, while canonical Class II transcription activators are
either homodimers or contain multiple DNA binding mo-
tifs that confer high specificity and affinity for target DNA
(10,23). Second, holo-WhiB1 does not bind to its own pro-
moter and no target gene of holo-WhiB1 has been iden-
tified thus far (6), while 704-binding transcription activa-
tors are typically self-regulated, activating gene expression
by binding to specific promoter sequences and recruiting
RNAP to the target genes (10,25). An in-depth mechanis-
tic understanding of transcriptional regulation by WhiB1
requires atomic-resolution structural information showing
how holo-WhiB1 interacts with A4. An NMR structure
of free holo-WhiB1 has been reported (8), but there is no
3D structural information available for A-bound WhiB1
or any other Wbl proteins.
In the course of defining the molecular mechanism of
holo-WhiB1 in A4-dependent transcriptional regulation,
we solved a crystal structure of holo-WhiB1 in complexwith
the C-terminal domain of A (ACTD) containing the intact
A4 region. Our structural analysis reveals that hydropho-
bic residues unexpectedly dominate the interaction between
holo-WhiB1 and A. This is distinctly different from previ-
ously characterized Class II transcription activators, which
typically interact loosely with region 4 of 70-family pri-
mary sigma factors through polar residues on the surface
(11,12,26,27). In vitro, the observed transcription repression
by holo-WhiB1 via interaction with A4 further supports
the hypothesis that WhiB1 regulates gene expression in a
manner distinct from the canonical transcription activation
by A4-bound Class II activators. In addition, the local pro-
tein environment of the Fe−S cluster in the WhiB1:ACTD
complex explains how the complex formation renders this
typically O2-labile cluster into a remarkably O2-stable [4Fe–
4S] cluster that can sense NO in aerobic bacteria.
MATERIALS AND METHODS
Bacterial strains and growth media
The bacterial strains and plasmids used in this study are
listed in Supplementary Table S1. All the E. coli strains
used for cloning and protein over-expression were grown in
Luria–Bertani (LB) media supplemented with suitable an-
tibiotics as needed at 37 ◦C with shaking at 200 rpm, unless
otherwise specified.
Mycobacterium smegmatisMC2 155 (M. smegmatis) and
the related whiB1 mutants generated in this study were
grown in either Middlebrook 7H9 broth or on 7H10 agar
(BD DifcoTM) supplemented with 10% (v/v) ADC (2%
dextrose, 5% bovine serum albumin, 0.85% NaCl and
0.003% catalase), 0.2% (v/v) glycerol, 0.05% (v/v) Tween
80 (Sigma) and suitable antibiotics as needed.
Creation of a conditional whiB1 knockout mutant in M.
smegmatis
The whiB1 (MSMEG 1919) knockout mutant inM. smeg-
matis was generated using homologous recombination-
based in-frame unmarked deletion as previously described
(28). Briefly, a 844-bp DNA fragment upstream of whiB1
and a 1135-bp DNA fragment downstream of whiB1 were
amplified by PCR from the genomic DNA of M. smeg-
matis and cloned into pUC-Zeo flanking the zeocin re-
sistance gene to construct the recombinant plasmid pUC-
Zeo+MsmwhiB1LR. After confirming the construct by
DNA sequencing, a linear recombinant DNA fragment was
prepared by double digestion of pUC-Zeo+MsmwhiB1LR
withKpnI andHindIII. The resulting linearDNA fragment
was electroporated into an M. smegmatis strain contain-
ing the helper plasmid pJV53-GFP to allow the expression
of recombination proteins gp60 and gp61 of mycobacterio-
phage Che9c (29). Transformants were selected on 7H10
agar plates supplemented with 25 g/ml kanamycin and 50
g/ml zeocin. As reported for M. tuberculosis (6), no vi-
able whiB1 deletion mutants were obtained after multiple
attempts, although single crossover was observed.
To confirm that whiB1 is essential in M. smegmatis, we
created a conditional whiB1 knockout mutant as shown in
Supplementary Figure S1. For this purpose, the DNA frag-
ment containing the 3FLAG-tagged whiB1 gene with its
Nucleic Acids Research, 2020, Vol. 48, No. 2 503
flanking sequences (1159 bp upstream and 638 bp down-
stream of whiB1, respectively) was cloned into the inte-
gration plasmid pKW08-Lx-Int (30). The resulting plas-
mid pKW08 + 3FLAGwhiB1LR was transformed and in-
tegrated in the genome of M. smegmatis to obtain a com-
plementary copy of whiB1 under its native promoter in
the genome of M. smegmatis. This strain was used for
subsequent deletion of whiB1 at its native location as de-
scribed above. Several colonies from the screening plates
were streaked on 7H10 agar plates without antibiotics to
facilitate excision of the zeocin cassette. The conditional
whiB1 knockoutmutant from the resulting colonies was ver-
ified by PCR and further confirmed by DNA sequencing
(Supplementary Figure S1).
Site-directed mutagenesis of whiB1 inM. smegmatis
To generate site-directed whiB1 mutants in M. smegma-
tis, a template plasmid pUC-Hyg+MsmwhiB1SDM was
first constructed with a 612-bp DNA fragment containing
the whiB1 gene and its upstream DNA flanking the left
arm, and a 1135-bp DNA fragment downstream of whiB1
flanking the right arm of the hygromycin resistance gene,
respectively. Desired single point mutations of whiB1 in
pUC-Hyg+Msm-whiB1SDM were constructed using Q5®
Site-Directed Mutagenesis Kit (New England Biolabs) ac-
cording to the manufacturer’s instructions and confirmed
by DNA sequencing. Linear recombinant DNA fragments
were then prepared from the resulting plasmids by dou-
ble digestion with KpnI and HindIII, and electroporated
into anM. smegmatis strain containing the helper plasmid
pJV53-GFP. The homologous recombination procedures
for generating site-directed whiB1 mutants were similar to
those used in creating the whiB1 deletion mutant, as previ-
ously described (28). The resulting whiB1mutants were ver-
ified by PCR and further confirmed by DNA sequencing.
Plasmid construction for protein over-expression in E. coli
The DNA sequences encoding the wildtype WhiB1
(Rv3219, 1–84 aa) and the C-terminal domain of A
(Rv2703) containing the C-terminal residues 359–528 of
the protein (denoted AC170) were amplified by PCR from
M. tuberculosis H37Rv genomic DNA (a gift from Dr. Mi-
dori Kato-Maeda’s group at the University of California,
San Francisco). The whiB1 gene was cloned into pET19b
and the σAC170 gene was cloned into pCDF-1b to express
His10-WhiB1 and His6-AC170, respectively. These plasmids
were then further modified for expressing the truncated
and mutant proteins used for crystallization and pull-down
assays.
For preparing tagless WhiB1 used in in vitro pull-down
assays and in vitro transcription, the whiB1 gene was cloned
into pETDuet-His6-SUMO vector (modified from pET-
Duet). For co-expression and purificationwithHis6-AC170,
the whiB1 gene was cloned into the pET28b vector to
express the tagless WhiB1 wildtype and mutant proteins.
The pET21b-MtbWhiB1–76 and pET28b-6HisMtbAC112
plasmids were used for over-expressing and purifying the
WhiB1:AC112 complex used for crystallization.
All the plasmids were confirmed by DNA sequencing be-
fore being transformed intoE. coliBL21-Gold (DE3) strain
for protein expression.
General procedures for protein expression, purification and
analysis
Over-expression of proteins for structural and biochemi-
cal studies was done in E. coli BL21-Gold (DE3). Protein
expression was induced by adding 100M isopropyl β-D-
thiogalactopyranoside (IPTG, Sigma-Aldrich) to the cell
culture at 16 ◦C for 12–15 h grown in Terrific Broth. For
over-expression of proteins containing a [4Fe–4S] cluster,
100 M ferric ammonium sulfate was added to the cell cul-
ture before induction. Cells were collected by centrifugation
and kept at −80 ◦C for storage.
Affinity purification of His-tagged proteins containing
WhiB1 (wildtype and mutants) was carried out using a His-
Trap HP column (GE Healthcare Life Sciences) at room
temperature either in an anaerobic chamber (Coy Lab) or
under a customized Schlenk Line, unless otherwise speci-
fied. All the buffers used for protein purification were thor-
oughly degassed under the Schlenk Line and supplemented
with 1 mM 1,4-dithiothreitol (DTT) immediately before
use. Purification of His6-A or His6-AC170 was performed
at 4◦C under aerobic conditions to minimize degradation.
Phenylmethanesulfonyl fluoride (PMSF at 1 mM, Sigma-
Aldrich) and the Roche Protease Inhibitor Cocktail (at 1
tablet/100 ml buffer) were added to the lysis buffer to re-
duce degradation of target proteins. Imidazole in the eluted
fractions was removed by passing through either a desalt-
ing column or a Superdex 200 column (GE Healthcare Life
Sciences). Samples after each step of purification were an-
alyzed by SDS-PAGE and by UV-Visible (UV-Vis) spec-
troscopy. Unless otherwise specified, the final purified pro-
teins in 50mM Tris−HCl, pH 8.0, 100mM NaCl, 1mM
DTT were stored in liquid nitrogen until use.
The selenomethionine (SeMet)-substituted
WhiB1:AC112 protein used for single wavelength anoma-
lous diffraction (SAD) phasing was expressed in E.
coli BL21-Gold (DE3) by the metabolic inhibition method
as previously described (31) and purified by Ni2+-affinity
chromatography and gel filtration as described above.
For preparing tagless WhiB1 used in the pull-down as-
says and in vitro transcription, the SUMO tag was removed
from the purified His6-SUMO-WhiB1 by the SUMO pro-
tease Ulp1 (Thermo Fisher Scientific). The resulting sample
was passed through HisTrap HP column to remove undi-
gested protein and Ulp1, and further purified by gel filtra-
tion.
Expression and purification of theM. tuberculosis RNA
polymerase core enzyme from E. coli was carried out as
previously described (32). The plasmid used for expression
of the M. tuberculosis RNA polymerase core enzyme was
received from Dr Robert Landick’s group at the Univer-
sity of Wisconsin–Madison and used without any modifi-
cation. M. tuberculosis RNA polymerase holoenzyme was
prepared by mixing the purifiedM. tuberculosisRNA poly-
merase core enzyme with excess His6-A, and passing the
mixture through a gel filtration column (Superose 6 increase
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10/300 GL, GE Healthcare Life Sciences) to remove un-
bound His6-A.
UV-Vis spectra of the purified proteins were recorded us-
ing an HP 8452a diode array UV-Vis spectrophotometer
(Agilent Technologies Inc.). Protein concentrations were es-
timated by the Pierce Bradford Assay Kit (Thermo Fisher
Scientific) and by the absorption at 280 nm. The absorption
at 410 nm, which is characteristic of proteins containing
[4Fe–4S]2+ clusters (15,33), was used to estimate the occu-
pancy of the [4Fe–4S]2+ cluster in the protein samples con-
taining WhiB1.
Western blot analysis of 3FLAG-tagged proteins was
detected by chemiluminescence using mouse anti-FLAG
M2 antibody (Sigma) as the primary antibody and the
horseradish peroxidase-coupled goat anti-mouse IgG anti-
body (Jackson ImmunoResearch Laboratories) as the sec-
ondary antibody.
Crystallization
Initial crystallization screens of the WhiB1:AC112 complex
were carried out at 18◦C in a Coy anaerobic chamber using
the sitting-drop vapor diffusion method, followed by op-
timization of the crystallization hits. High-quality crystals
were obtained by mixing 1l of WhiB1:AC112 at 70 mg/ml
with an equal volume of the reservoir solution containing
100 mM Bis-Tris pH 5.5, 200 mM MgCl2 and 25% (w/v)
PEG3350. Crystals of the SeMet-substitutedWhiB1:AC112
were produced under the same conditions. All the crystals
were briefly soaked in the reservoir solution supplemented
with 20% glycerol for cryoprotection before flash-cooling in
liquid nitrogen.
The AC112 protein in the complex was partially degraded
during the crystallization process based on SDS-PAGE
analysis and peptide identification bymass spectrometry. In
the high-quality single crystals used for X-ray crystallogra-
phy, partially degraded AC112 showed a similar apparent
size as WhiB1 on the SDS-PAGE gel (Supplementary Fig-
ure S2).
X-ray crystallographic data collection, structural determina-
tion and analysis
X-ray diffraction data were collected at the beamlines 9-
2 and 12-2 of the Stanford Synchrotron Radiation Light-
source from single crystals maintained at 100 K using a 6M
Pixel Array Detector. The SAD data were collected from
a single SeMet-substituted WhiB1:AC112 crystal at the Se
K-edge absorption peak (12,679 eV). The diffraction data
were indexed, integrated and scaled with either HKL2000
orXDS (34,35). Two different crystal forms,C2221 andP21,
were found in the crystals produced from different batches
of crystallization.
Experimental phases were determined by SAD with
Phenix.Autosol (36), using the SeMet-substituted
WhiB1:AC112 diffraction data up to 2.1 A˚ resolution.
Since no crystal of the native WhiB1:AC112 diffracted
better than 2.3 A˚, the same dataset used for experiment
phasing was used for structure refinement with a resolution
cutoff extended to 1.85 A˚ considering the high multiplicity
of the data and the CC1/2 of 0.882 in the highest resolution
shell.
Model building and structure refinement were carried
out using COOT and Phenix (37,38). Two copies of the
WhiB1:ACTD complexmolecules were found in each asym-
metrical unit of the C2221 form and four copies in the P21
form. Residues 2–73 of WhiB1 and residues 454–521 of
ACTD were included in the final model for the complexes of
both crystal forms, while residues 2–75 of WhiB1 and 454–
523 of ACTD were included in at least one subunit of the
refined model in the C2221 form. Notably, the structures of
theWhiB1:ACTD complex determined from theC2221 and
P21 forms agree closely, except for the flexible loop region
containing residues Val20-Ala26 in WhiB1. The data col-
lection and refinement statistics are summarized in Table 1.
Because of the better-defined electron density of residues at
the N- and C-terminus, the refined structure in the C2221
form was used for generating the figures and analyzing the
structure as described in the main text.
Structural figures were prepared with the PyMol Molec-
ular Graphics System v 2.3 (http://www.pymol.org). Se-
quence and structural alignments were performed inClustal
Omega and ESpript online server (http://espript.ibcp.fr), re-
spectively (39,40). Tunnel dimensions were calculated using
the Caver 3.0 software with probe radii indicated in the fig-
ures (41).
In vitro and in vivo protein-protein interaction assays
The interactions between WhiB1 and His6-AC170 (wild-
type and mutants) were carried out using two different
approaches––in vitro pull-down assay and co-expression
and affinity purification––to verify the effect of single muta-
tions in either WhiB1 or AC170 on the WhiB1:AC170 com-
plex formation.
For the in vitro pull-down assays, an equal amount of
the purified His6-AC170 protein (wildtype or mutant) in
50mM Tris–HCl, pH 8.0, 100mM NaCl, 1 mM DTT was
pre-loaded onto Ni2+-NTA Sepharose resin (GE Health-
care Life Sciences). An excess of tagless WhiB1 (either pu-
rified wildtype or the whole cell supernatant containing an
over-expressedWhiB1mutant) protein was thenmixed with
immobilized His6-AC170 on the Ni2+ Sepharose resin. Af-
ter incubating for 5 minutes with gentle mixing followed by
extensive washing with the same buffer containing 50 mM
imidazole, His6-AC170 (alone or in complex with WhiB1)
was eluted in the same buffer containing 250 mM imidazole
and analyzed by SDS-PAGE. A negative control of theNi2+
Sepharose resin without pre-incubated with His6-AC170
was used to exclude the possibility that taglessWhiB1 binds
nonspecifically to the Ni2+ resin.
For the co-expression and affinity purification method,
two plasmids containing genes encoding His6-AC170 and
tagless WhiB1 (either wildtype or mutant), respectively,
were co-transformed in E. coli BL21-Gold (DE3) strain.
Protein co-expression and purification was performed sim-
ilarly as described above, except that loose Ni2+ Sepharose
HP resin was used for batch affinity purification of the
His6-AC170-bound tagless WhiB1 (either the wildtype or
mutants) simultaneously. For each sample, the whole cell
supernatant from an equal amount of the cell pellet was
mixed with Ni2+ Sepharose HP resin that had been pre-
equilibrated in buffer containing 50mM Tris–HCl, pH 8.0,
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Table 1. Data collection and refinement statistics
Crystal 1 Crystal 2 Crystal 1 data for phasing
Data collectiona
Space group C2221 P21 C2221
Cell dimensions
a, b, c (A˚) 37.4, 114.1, 144.7 37.8, 144.4, 59.9 37.4, 114.1, 144.7
, ,  (◦) 90.0, 90.0, 90.0 90.0, 106.8, 90.0 90.0, 90.0, 90.0
Wavelength (A˚) 0.9793 0.9793 0.9793
Resolution (A˚) 50–1.85 (1.88–1.85) 50–1.85 (1.87–1.85) 50–2.10 (2.16–2.10)
Rmerge 0.095 (0.894) 0.061 (1.42) 0.073 (0.629)
I / I 36.8 (0.84) 22.3 (1.9) 24.3 (4.7)
Completeness (%) 91.5 (56.4) 98.3 (98.3) 99.3 (93.7)
Multiplicity* 22.1 (13.2) 14.0 (14.4) 26.4 (26.8)
CC1/2(%) 99.8 (82.2) 99.9 (86.2) 99.3 (98.3)
Refinement
Resolution (A˚) 50–1.85 (1.95–1.85) 50–1.85 (1.92–1.85)
No. reflections 20218 51328
No. molecules per asymmetric unit 2 4
Rwork/Rfree 0.189/0.236 0.193/0.234
No. atoms 2531 4821
Protein 2266 4472
Ligand 30 39
Water 235 310
B-factors 34.94 50.54
Protein 34.47 50.64
Ligand 34.82 42.34
Water 39.54 50.12
R.m.s deviations
Bond lengths (A˚) 0.007 0.01
Bond angles (◦) 1.16 1.21
Ramachandran statistics
Favored regions (%) 99.63 98.87
Allowed regions (%) 0.37 1.13
Outliers (%) 0 0
PDB ID 6ONO 6ONU
aThe highest-resolution shell statistics are shown in parentheses.
*For the data used for phasing, the anomalous multiplicity was shown.
100mMNaCl, 1 mMDTT. The resin was then washed with
the same buffer containing 50 mM imidazole, followed by
eluting the target proteins with the same buffer containing
250 mM imidazole. The eluted protein samples were ana-
lyzed by UV-Vis absorption spectroscopy and SDS-PAGE.
Electrophoretic mobility shift assay (EMSA)
The whiB1 promoter (PwhiB1) was amplified from theM. tu-
berculosisH37Rv genomic DNA (from 3595416 to 3595712
bp) and cloned into the EcoRI/HindIII site of the pUC18
vector. The resulting plasmid, pUC18-PwhiB1, was used
as the template for preparing a biotin-labeled DNA probe
using the 5′-biotin labeled M13F and M13R primers. The
EMSA experiments were performed using the LightShift
Chemiluminescent EMSA Kit (Thermo Fisher Scientific)
as previously described (6,19). The biotin-labeled probe (0.2
nM) was incubated with 0–12 M of His6-A or His6-
AC170, either alone or pre-mixed with equimolar amounts
of WhiB1, in 100 mM NaCl, 40 mM Tris–HCl, pH 8.0, 10
mM MgCl2, 1 mM EDTA, 0.25 mg/ml BSA and 1 mM
DTT in a total volume of 20 l. 50 ng/l Poly (dI-dC) was
included in all reactions as a non-specific competitor. After
incubation on ice for 20min, the reactionmix was subjected
to electrophoretic separation in a 6% native polyacrylamide
gel at 100 V in 0.5 × TBE buffer. DNA and DNA-protein
complexes were transferred from the gel to a Hybond-N+
nylon membrane (GE Healthcare Life Sciences) and UV
cross-linked to the membrane. The biotin-labeledDNAwas
detected using the LightShift Chemiluminescent EMSAKit
according to the manufacturer’s instructions.
In vitro transcription assays
The rrnAP3 DNA template used for in vitro transcrip-
tion assays was amplified by PCR from the M. tubercu-
losis H37Rv genomic DNA (from 1471524 to 1471892 bp
with an expected transcription product of 245 nt includ-
ing 8 nt from the primer in the 3’ end) and confirmed by
DNA sequencing. For each 20-l reaction, 250 nM RNAP
holoenzyme was mixed with the desired amount of tagless
WhiB1 (wildtype or F17A mutant) in the KCl assay buffer
(10 mM Tris–HCl, pH 8.0, 50 mM KCl, 10 mM MgCl2,
0.1 mM EDTA, 0.1 mM DTT, 50 g/ml BSA). A negative
control reaction was performed simultaneously using 250
nM RNAP core enzyme without A and WhiB1. The reac-
tion mixtures were incubated for 10 min at room temper-
ature under anaerobic conditions. The rrnAP3 DNA tem-
plate was then added to each reactionmixture at a final con-
centration of 50 nM and incubated at room temperature for
an additional 10 min. Transcription was initiated by adding
NTP mix (ATP, CTP and GTP at a final concentration
of 100 M) and 1.0 Ci of [-32P]UTP (800 Ci mmol−1,
PerkinElmer Life Sciences). After incubation at 37◦C for 5
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min, the reaction was stopped with a 2X Stop buffer (45
mMTris–HCl, 45 mMboric acid, 8M urea, 30 mMEDTA,
0.02% bromophenol blue, 0.02% xylene cyanol). Transcrip-
tion products were denatured by heating at 95◦C, separated
on polyacrylamide gels, and visualized using a phosphorim-
ager.
RESULTS
Crystallization and structural determination of theM. tuber-
culosisWhiB1:ACTD complex
To improve protein stability and enable crystallization of
the WhiB1:ACTD complex, we made a truncated WhiB1
(aa 1–76) construct that lacks the unstructured C-terminal
loop, and a A construct that contains only the last 112
residues (aa 417–528). The constructs were designed based
on the previously reported NMR structure of free WhiB1
and the cryo-EM structure of A in the M. tuberculosis
RNAP holoenzyme (8,32). The resulting WhiB1 (without
a tag) and A (with a His6 tag) constructs were then co-
expressed and purified from E. coli, and crystallized un-
der anaerobic conditions (seeMATERIALSANDMETH-
ODS).
Experimental phases were determined by single-
wavelength anomalous dispersion (SAD) from the SeMet-
substituted WhiB1:AC112 complex, and the structure was
solved and refined at 1.85 A˚ resolution using Phenix and
COOT (see MATERIALS ANDMETHODS, Supplemen-
tary Figure S3) (37,38). The data processing and refinement
statistics are summarized in Table 1.
Overall structure of the WhiB1:ACTD complex
The structure of the WhiB1:ACTD complex shows that
WhiB1 and ACTD interact with each other at the [4Fe–4S]
cluster binding pocket of WhiB1 (Figure 1). An all-helical
fold is adopted by both WhiB1 and ACTD, with helices
hw1–4 of WhiB1 and hs1–4 of ACTD, respectively (Figure
1B and C). The complex is hinged at the [4Fe–4S] cluster
and forms a clamp between theC-terminal helices ofWhiB1
(hw4) and ACTD (hs4) (Figure 1B), both of which have been
implicated in DNA binding (19,32,42,43).
Structural comparison demonstrates that both WhiB1
and ACTD undergo conformational changes upon form-
ing the complex. An overlay of the WhiB1:ACTD complex
with the NMR structure of free WhiB1 reveals a global
structural rearrangement upon ACTD binding (8). This in-
cludes changes in the inter-helical and helix-loop interac-
tions, and the breaking of helix hw1 into two shorter helical
regions (hw1a and b) (Figure 1D). Helix hw4 and the follow-
ing C-terminal DNA binding motif move concomitantly
with the structural rearrangement. In the NMR structure
of free WhiB1, helix hw4 is interlocked with hw2, which has
been cited to explain why free holo-WhiB1 does not bind
to DNA (8). In the WhiB1:ACTD complex helix hw4 of
WhiB1 is about 120◦ apart from its corresponding position
in free WhiB1 and is released from hw2 (Figure 1D). The
conformation of hw4 in the complex appears stabilized by
the interaction with hw3. The hw4 conformation may also
be stabilized in part by crystal contacts betweenWhiB1 and
ACTD´ in the second complex molecule of the asymmetric
unit (Supplementary Figure S3), while it is expectedly more
flexible in solution. The overall conformation of ACTD in
the complex is similar to that in the Mtb RNAP holoen-
zyme, except for the C-terminus of helix hs4 (Figure 1E).
The molecular interface of WhiB1 and ACTD
Our structural analysis indicates that the interaction be-
tween WhiB1 and ACTD involves considerable hydropho-
bic contacts around the [4Fe–4S] cluster binding pocket. As
shown in Figure 2, His516 and Pro517 in the C-terminal
loop of ACTD insert into the [4Fe–4S] cluster binding
pocket ofWhiB1. There is a cluster of hydrophobic residues
around the Fe–S cluster binding pocket, including Trp3,
Phe17, Trp60 and Phe18 (Figure 2, Supplementary Table
S2). Each of these aromatic residues is highly conserved in
WhiB1 across different classes of the phylum Actinobacte-
ria (Supplementary Figure S4).
To test the importance of these hydrophobic residues for
the interaction of WhiB1 with ACTD, His516 and Pro517
were substituted with Ala in AC170 (containing the last
170 residues 359–528 of A and the intact A4). Protein-
protein interaction assays with AC170 H516A and P517A
mutants indicate that these hydrophobic residues are critical
forWhiB1 binding. Substitution of either His516 or Pro517
by Ala completely abolishes the interaction betweenWhiB1
and AC170 as observed both in vitro pull-down assay and
in co-expression and affinity purification, establishing the
functional importance of these residues (Figure 2C, Supple-
mentary Figure S5). Likewise, an F17A or F18A substitu-
tion inWhiB1 abolishes the interaction betweenWhiB1 and
AC170, while neither shows a significant effect on [4Fe–4S]
cluster binding in WhiB1 (Figure 2D, Supplementary Fig-
ures. S5 and S6). Substitution of the Trp residues in WhiB1
shows varied effects on complex formation as well as the
stability of the [4Fe–4S] cluster, which is discussed in detail
in the following section.
Besides the aforementioned hydrophobic interactions, a
His516-centered hydrophilic network is also required for the
interaction between WhiB1 and ACTD. As highlighted in
Figure 2B, Nε2 of His516 forms a 2.8-A˚ hydrogen bond
with the carbonyl O of Val59. In addition, Nε2 of His516
is 3.5 A˚ away from a bridging sulfide (S4) in the [4Fe–4S]
cluster and thus it may form a polar interaction with the
cluster. To evaluate the importance of the His516-centered
hydrophilic network for the complex formation, we substi-
tutedHis516with Phe inAC170. TheAC170 H516Fmutant
completely abolishes binding toWhiB1 (Figure 2C, Supple-
mentary Figure S5). When replacing His516 with Phe in the
crystal structure, the shortest distance between the modeled
Phe and any non-bonded residues is∼2.4 A˚, suggesting that
the observed effect of the H516F mutation is more likely
due to disruption of the His516-centered polar interactions
rather than due to a steric effect considering the flexibility
of the loops in this region.
To test whether disruption of the WhiB1:A4 interac-
tion affects WhiB1’s essential role in mycobacteria, residues
Phe17 and Phe18 in whiB1, both of which are required
for A4 binding in vitro, were mutated to Ala and the im-
pacts on the cell growth in the non-pathogenic mycobacte-
rial modelMycobacterium smegmatis (M. smegmatis) were
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Figure 1. Overview of the WhiB1:ACTD complex from M. tuberculosis. (A) Domain organization of A and WhiB1 in M. tuberculosis based on the
primary and 3D structural analysis. The conserved domains are shown in rectangles, while the variable regions are represented by thin sticks. The regions
included in the refined crystal structure are indicated by the dash lines. (B and C) Cartoon and surface representation, respectively, of the WhiB1:ACTD
complex. The [4Fe–4S] cluster ofWhiB1 is shown in ball-and-stick representation, with Fe atoms colored orange and yellow for S. The clamp shape formed
between the C-terminal helices ofWhiB1 (hw4) and ACTD (hs4) is highlighted by the arrow. (D) Crystal structure ofWhiB1 in the complex is superimposed
with the NMR structure of free WhiB1 (PDB ID: 5OAY, in pink). Only the first model of the NMR structure is shown for clarity. (E) Crystal structure
of ACTD in the complex is superimposed to the cryo-EM structure of M. tuberculosis RNA polymerase – DNA complex (PDB ID:6C04, in pink). The
region different between the two structures at the C-terminus of ACTD is highlighted in the circle.
assessed. All M. tuberculosis Wbl proteins except WhiB5
are highly conserved in M. smegmatis. In particular, the
WhiB1 proteins from M. Smegmatis and M. tuberculosis
share 96% sequence identity, with variations in only three
residues (Supplementary Figure S4). Moreover, as demon-
strated in M. tuberculosis (6), deletion of whiB1 is lethal
in M. smegmatis unless a complementary copy of whiB1 is
present (see MATERIALS and METHODS, Supplemen-
tary Figure S1). These results establish thatM. smegmatis is
a suitable mycobacterial model for the functional studies of
WhiB1.We found that substitution of either Phe17 or Phe18
with Ala in whiB1 is lethal inM. smegmatis, consistent with
their essential role in the WhiB1:AC170 interaction in vitro.
These results indicate that the interaction between WhiB1
and A4 is required for WhiB1’s essential role in mycobac-
terial growth.
Surface charge complementarity is a common mecha-
nism used by 704-bound transcription activators (7,11,12)
but it does not seem to be a critical mechanism for stabi-
lizing the WhiB1:ACTD complex. As shown in Figure 2A,
there are two regions in the complex interface that con-
tain oppositely charged residues (Arg4 andArg10 inWhiB1
versus Ser518 and Ser520 in ACTD; Glu15 and Gln55 in
WhiB1 versus Lys513 and Arg515 in ACTD). However, the
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Figure 2. Molecular interface of WhiB1 and ACTD. (A) Open-book view of Figure 1C. Residues in contact at the interface of WhiB1 and ACTD are
labeled, with the hydrophobic residues colored brown and the charged residues at the surface colored wheat, respectively. (B) Close-up view of the insertion
of His516 and Pro517 of ACTD into the [4Fe–4S] cluster binding pocket of WhiB1, surrounded by four aromatic residues (Trp3, Phe17, Phe18 and Trp60)
shown in sticks. The polar interactions of the His516 imidazole ring with Val59 and the [4Fe–4S] cluster, respectively, in WhiB1 are highlighted by red dash
lines. The [4Fe–4S] cluster of WhiB1 is shown in ball-and-stick representation, with the carbon atoms of WhiB1 and in ACTD colored palegreen and grey,
respectively; Fe in orange; N in blue; O in red; and S in yellow. (C) and (D) are the SDS-PAGE analyses of the samples from in vitro pull-down assays. In
Panel C, the purified His6-AC170 proteins (either wildtype or mutants as indicated) were used as the bait, and the purified tagless wildtype WhiB1 protein
was used as the prey. In PanelD, the purified wildtype His6-AC170 protein was used as the bait, and the whole cell supernatant containing a tagless WhiB1
mutant was used as the prey. The purified tagless WhiB1 and His6-AC170 were loaded in the first two lanes in Panel C as reference. In the negative control
(NC), only tagless WhiB1 was used in the pull-down assay without the presence of the bait (His6-AC170).
residue contacts in these two regions vary significantly be-
tween two copies of the complex molecules in the asym-
metric unit of the crystal structure (Supplementary Ta-
ble S3), suggesting that they do not drive complex forma-
tion. As expected, a single mutation of the selected residues
(Glu15 in WhiB1; Lys513, Arg515, Ser518 and Ser520 in
ACTD) in these two regions did not show significant ef-
fects on the WhiB1:AC170 complex formation (Figure 2C
and D, Supplementary Figure S5). Arg515 lies close to the
WhiB1:ACTD interface. While this residue is required for
A binding and transcription activation by severalM. tuber-
culosisWbl proteins, it is not required by WhiB1 (7,11,12).
In the crystal structure of WhiB1:ACTD, the sidechain of
Arg515 protrudes out towards the solvent and does not
make close contacts with any residues in WhiB1, explain-
ing why Arg515 in WhiB1 is not required for A binding.
Taken together, our structural analyses and protein-
protein interaction assays demonstrate that the formation
of the WhiB1:ACTD complex is driven by a combination
of hydrophobic contacts and His516-centered polar inter-
actions inside the Fe–S cluster binding pocket, instead of
surface charge complementarity. The site-directed mutage-
nesis studies on whiB1 inM. smegmatis support that the in-
teraction withA is required for the essential role ofWhiB1,
revealing a potential mechanism of action for holo-WhiB1
in supporting mycobacterial growth.
The local environment of the [4Fe–4S] cluster binding pocket
in the WhiB1:ACTD complex
The WhiB1:A complex has been reported to be O2–stable
(8). This differs from other structurally-characterized gas
molecule sensors containing a [4Fe–4S] cluster, for exam-
ple the O2/NO sensor FNR and the NO sensor NsrR, both
of which are highly sensitive to O2 (44–47). Examination
of the local environment surrounding the [4Fe–4S] cluster
in the WhiB1: ACTD complex reveals the structural ba-
sis for its exceptional O2 stability. As shown in Figure 3A,
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Figure 3. Structural basis for the stability of the [4Fe–4S] cluster in the WhiB1:ACTD complex. (A) Comparison of the crystal structure of the ACTD–
boundWhiB1 with the NMR structure of free WhiB1 (PDB ID: 5OAY) aligned at the Fe-S cluster binding site. Only the first model of the NMR structure
is shown for clarity. The [4Fe–4S] cluster and the aromatic residues near the cluster for the ACTD–boundWhiB1 are shown in the ball-and-stick and stick
representation, respectively; while their corresponding residues in free WhiB1 are shown in thin lines. The carbon atoms are colored pale green for the
ACTD–bound WhiB1 and grey for free WhiB1. Other non-carbon atoms in this figure are colored by the element type: blue for N, red for O, orange for
Fe and orange and yellow for S. (B) Stick representation of the local environment of the [4Fe–4S] cluster binding pocket. The [4Fe–4S] cluster is shown
in ball-and-stick representation. The carbon atoms are colored pale green for WhiB1 and grey for ACTD. (C) Solvent-accessible paths from the surface
towards the [4Fe–4S] cluster in FNR (PDB ID: 5E44) and NsrR (PDB ID:5N07) were calculated by CAVER with a shell radius of 1.4 A˚, which is the
assumed radius cutoff for solvent molecules. The paths are highlighted in pink and the minimum bottleneck of each path is indicated. No solvent-accessible
path is found in the WhiB1:ACTD complex with a shell radius of 1.4 A˚. Instead the largest tunnel found in the WhiB1:ACTD complex with the minimum
bottleneck of 0.8 A˚ is shown for demonstration and is highlighted in cyan.
the protein environment surrounding the [4Fe–4S] cluster
binding site is altered in the WhiB1:ACTD complex rela-
tive to free WhiB1. The most noticeable differences include
four aromatic residues (Trp3, Phe17, Phe18 and Trp60)
that are closer to the Fe–S cluster binding pocket, while
the side chain of Trp49 faces away from the cluster in the
WhiB1:ACTD complex relative to free WhiB1.
As a result of the conformational changes upon A4
binding, the [4Fe–4S] cluster of the complex is enclosed in
a hydrophobic core consisting of several short-chain hy-
drophobic residues besides the three aromatic residues of
WhiB1 (Trp3, Phe17 and Trp60) and His516 and Pro517
of ACTD mentioned above (Figure 3B). The side chains
of the polar residues (Arg4, Arg10 and Thr43 in WhiB1
and Ser518 in ACTD) around the [4Fe–4S] cluster all pro-
trude from the cluster, with the sole exception of His516
in ACTD. Apart from the imidazole ring of His516, six
backbone amides are found within 4 A˚ of the sulfur lig-
ands of the [4Fe–4S] cluster in the complex. The dipoles
of these peptide backbone amides may stabilize the cluster
via a protein-derived electrostatic field (48,49). Cavity anal-
ysis indicates that the biggest channel extending from the
WhiB1:ACTD surface to the [4Fe–4S] cluster has a mini-
mum bottleneck of∼0.8 A˚. Assuming a 1.4-A˚ radius cutoff
for water molecules, this indicates that the solvent accessi-
bility to the [4Fe–4S] cluster in the complex is highly limited
(Figure 3C). In contrast, multiple channels with aminimum
bottleneck of ∼1.4 A˚ or larger to the [4Fe–4S] cluster in ei-
ther FNR or NsrR homodimer structures have been iden-
tified by cavity analysis, suggesting that the Fe-S clusters of
these two proteins remain fully accessible to solvent. Our
cavity analysis indicates that solvent accessibility is corre-
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lated with the O2 stability of the [4Fe–4S] clusters in these
proteins.
The characteristics of the local environment around the
[4Fe–4S] cluster in theWhiB1:ACTD complex resemble that
of the high potential iron-sulfur proteins (HiPIPs) involved
in electron transport (50,51). As indicated by the name,
HiPIPs have an unusually high redox potential compared
to many other [4Fe–4S] ferredoxins, and undergo a 3+/2+
rather than 2+/1+ redox cycle under physiological condi-
tions (48). HiPIPs are O2-stable owing to their high redox
potentials, but remain reactive to NO (52,53). The presence
of a hydrophobic barrier composed of aromatic residues,
solvent inaccessibility of the [4Fe–4S] cluster, and electro-
static interactions with local backbone amides have been
suggested to play a major role in improving the O2 stabil-
ity of HiPIPs (48,49,51,54). We predict that similar features
of the local environment surrounding the [4Fe–4S] cluster
in theWhiB1:ACTD complex may increase its redox poten-
tial as in HiPIPs and thus improve the cluster stability in the
presence of O2.
To identify the critical residues near the Fe–S cluster and
to test whether aromatic residues and/or solvent accessibil-
ity contribute to the stability of the [4Fe–4S] cluster in the
WhiB1:ACTD complex as demonstrated in HiPIPs, we car-
ried out an alanine scanning mutagenesis of the three Trp
residues near the cluster in WhiB1. The first Trp residue we
examined is Trp3. As shown in Figure 3A, Trp3 is close to
the [4Fe–4S] cluster of the complex and stands at the protein
surface facing bulk solvent in this crystal structure. Cavity
analysis predicts that a W3A mutation would open a pore
in the cluster binding pocket large enough for solvent access
to the cluster in the complex (Figure 4A). However, Trp3 is
far from the Fe–S cluster (>7.5 A˚ in all models) in theNMR
structure of free WhiB1, and no conformational change of
Trp3 was detected upon A binding by the NMR chemi-
cal shift perturbation analysis (8). To evaluate the effect of
Trp3 on the Fe-S cluster stability in free WhiB1 and in the
WhiB1:ACTD complex, we characterized the WhiB1 W3A
mutant in vitro and in M. smegmatis. As shown in Supple-
mentary Figure S5, we found that the W3A mutation in
WhiB1 results in a severe loss of the [4Fe–4S] cluster and
diminishes the stability of WhiB1 when expressed and puri-
fied alone. The W3A mutation also disrupts WhiB1’s inter-
action with AC170, most likely due to the instability of the
cluster (Supplementary Figure S5, Supplementary Figure
S6B). In M. smegmatis, the whiB1-W3A mutant showed a
significant defect in cell growth under optimal growth con-
ditions (Figure 4B). These observations unambiguously in-
dicate, that Trp3 is crucial for the stability of the Fe–S clus-
ter in WhiB1 and the interaction between WhiB1 and A,
consistent with our crystal structural analysis but different
from the reported NMR studies (8). These results also cor-
roborate that binding to A is required for WhiB1’s role in
mycobacterial growth as described above in themutagenesis
studies on Phe17 and Phe18 in WhiB1.
In contrast to Trp3, the WhiB1-W49A mutant protein
has properties comparable to those of the wildtype WhiB1
in SDS-PAGE and UV-Visible spectral analyses when co-
expressed and purified as a complex with His6-AC170 from
E. coli (Supplementary Figures S5C and S6B). However,
when expressed and purified alone from E. coli, WhiB1-
W49A exhibits a less stable [4Fe–4S] cluster based on the
UV-Visible spectra and has weaker binding to AC170 in the
in vitro pull-down assay (Figure 2D, Supplementary Figures
S5 and S6). These results indicate that Trp49 in WhiB1 un-
dergoes a conformational change upon ACTD binding as
suggested by the structural comparison between the NMR
structure of free WhiB1 and our crystal structure of the
WhiB1:ACTD complex (Figure 3A). Themutation of Trp60
(W60A), on the other hand, has little effect either on the
stability of the [4Fe–4S] cluster or on its binding to AC170
(Figure 2D, Supplementary Figures. S5 and S6). This is
likely because Trp60 is buried inside the Fe–S cluster bind-
ing pocket in the complex and is not exposed to the bulk
solvent.
Altogether, our structural and biochemical analysis in-
dicate that the unusually hydrophobic, solvent-inaccessible
local environment surrounding the [4Fe–4S] cluster in the
WhiB1:ACTD complexmakes the cluster remarkably stable
to O2 and thus favorable for NO sensing in aerobic environ-
ments.
WhiB1 represses transcription by interacting with A4 in the
RNAP holoenzyme
When superimposing ACTD in the WhiB1:ACTD complex
on the cryo-EM structure of the M. tuberculosis RNAP–
DNA complex, we find no steric clash between WhiB1 and
the core subunits in the RNAP holoenzyme (Figure 5A)
(32). We thus predict that WhiB1 can bind to A4 in the
RNAP holoenzyme. To test this, we first incubated either
the RNAP holoenzyme or core enzyme with and without
A, respectively, in the presence of an excess amount of the
3FLAG-tagged holo-WhiB1 under anaerobic conditions.
The mixtures were then separated by size exclusion chro-
matography, and the peak fractions were collected for SDS-
PAGE and western blot analysis. The results clearly demon-
strate that WhiB1 forms a stable complex with the RNAP
holoenzyme in a A–dependent manner (Figure 5B).
The superimposed structure also reveals that the clamp
comprising the C-terminal helix hw4 in WhiB1 and helix
hs4 in ACTD, is positioned across the DNA helix of the -
35 element in the RNAP–DNA complex (Figure 5A). Sev-
eral residues of ACTD implicated in DNA binding align
along the inner interface of the clamp and are in close con-
tact with DNA (the inset of Figure 5A) (32). Helix hw4 of
WhiB1 and the DNA binding motif immediately following
the C-terminus of this region straddle the DNA helix (the
inset of Figure 5A). However, none of the residues in the
C-terminal DNA binding motif of WhiB1 seem to be close
enough forDNAbinding in this superimposedmodel. Con-
sidering the flexibility of the loop structure on both ends of
WhiB1 hw4, we could not rule out the possibility that A–
boundWhiB1 is potentially involved in DNAbinding in so-
lution. To address this possibility, we examined the effect of
WhiB1 on A binding to the whiB1 promoter (PwhiB1) by
electrophoretic mobility shift assays (EMSAs). The results
from EMSA assays indicate that addition of WhiB1 to ei-
ther AC170 or A does not enhance its binding to PwhiB1
under the experimental conditions (Supplementary Figure
S7).
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Figure 4. Effect of Trp3 on the stability of the [4Fe–4S] cluster in the WhiB1:ACTD complex. (A) Solvent-accessible path from the surface towards the
[4Fe–4S] cluster in the mutated model of the WhiB1-W3A:ACTD complex was calculated by CAVER 3.0 with a shell radius of 1.4 A˚. The minimum
bottleneck of the path is 1.7 A˚. (B) Cell growth ofM. smegmatis wildtype (WT) and the whiB1-W3A mutant on either a 7H10 agar plate for 3 days (top)
or in 7H9 broth under optimal growth conditions. Error bars in the growth curves represent the standard deviation of triplicate samples.
To test whether the C-terminal DNA binding motif (AT-
hook) ofWhiB1 is required for its essential role inmycobac-
terial growth, we constructed a truncation mutant of whiB1
in M. smegmatis with a deletion of the AT-hook (whiB1-
ATD). In this mutant, the last 13 residues (Lys72–Val84),
including five Lys and Arg residues that are required for
DNA binding by apo-WhiB1 (19), are removed from the
whiB1 gene by homologous recombination-based in-frame
unmarked deletion (see MATERIALS AND METHODS,
Supplementary Figure S1D). As shown in Figure 5C, we
find that the growth rate of the whiB1-ATD mutant was
comparable to the wildtype strain under optimal growth
conditions, indicating that the single DNA binding motif of
WhiB1 is dispensable toM. smegmatis viability under non-
stressed conditions.
The results from our structural analysis and the mutage-
nesis study on the single DNA binding motif in WhiB1 de-
scribed above led us to search for an alternative mechanism
of transcriptional regulation by holo-WhiB1 different from
that of a canonical A4-dependent transcription activator.
A close examination of the overlaid structures between the
WhiB1:ACTD complex and M. tuberculosis RNAP indi-
cates that the WhiB1 binding site on A4 overlaps with the
C-terminal domain of the  subunit (CTD) in RNAP. CTD
is separated from the N-terminal domain of the  subunit
by a long flexible linker that is absent in most mycobacte-
rial RNAP structures (55). In E. coli and Bacillus subtilis,
CTD binds to the A/T-rich regions upstream of the −35
element (UP element) for transcription factor–independent
activation of many promoters, including the gene encoding
16S rRNA (56,57). A similar mechanism of transcriptional
regulation by CTD likely exists inM. tuberculosis based on
the 3D structure of RNAP and sequence analysis of poten-
tial UP elements in promoters (55). If so, WhiB1 binding to
ACTD may block the access of CTD to the UP element and
thus interfere with the CTD-dependent transcription.
To test this hypothesis, we examined the effect of WhiB1
on the in vitro transcription of the M. tuberculosis rrs gene
encoding 16S rRNA from the rrnAP3 promoter in M. tu-
berculosis (58). The results shown in Figure 5D indicate
a clear concentration–dependent transcription repression
from rrnAP3 by the wildtype WhiB1 but not the WhiB1-
F17A mutant, which does not bind to A4. Thus, we con-
clude that the transcription repression from rrnAP3 by
holo-WhiB1 requires its interaction with A4 under these
experimental conditions. To evaluate the effect of WhiB1
on the promoter escape, we examined the abortive tran-
scripts from the in vitro transcription reaction mixtures. As
shown in Supplementary Figure S9, we find that addition of
WhiB1 does not cause an increase in abortive transcripts,
which would be expected if WhiB1 repressed gene expres-
sion by inhibiting promoter escape. This observation is con-
sistent with our hypothesis that WhiB1 represses transcrip-
tion from rrnAP3 by preventing CTD from binding to the
UP element.
DISCUSSION
In the present report, we provide the first atomic view of
the molecular interface between WhiB1 and ACTD and es-
tablish the structural basis for the O2 stability of the [4Fe–
4S] cluster in the ACTD–bound WhiB1. We also demon-
strate that WhiB1 can repress gene expression by interac-
tion with A in the RNAP holoenzyme in vitro, and that
the interaction betweenWhiB1 and A4 is essential for sup-
porting mycobacterial growth in vivo. As discussed below,
these data suggest that WhiB1 regulates gene expression
by a non-canonical mechanism that is distinguished from
to the promoter-centered, Class II transcription activation
typically observed with 704–bound transcription activa-
tors (Figure 6) (10,23).
The crystal structure of the WhiB1:ACTD complex re-
ported here not only provides long-sought atomic detail
about the interaction between A4 and a Wbl protein, but
also reveals how amonomeric transcription regulatorwith a
single DNA binding motif interacts with A4 in bacteria. A
genome-wide survey of oligomerization states of transcrip-
tion factors from M. tuberculosis suggests that monomeric
transcription factors are more abundant than the few that
have been characterized (7). For example, two essential
monomeric transcription factors, RbpA and CarD, have
recently been identified as global transcription regulators.
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Figure 5. WhiB1 represses transcription from the rrnAP3 promoter in vitro by interaction with A in the RNA polymerase holoenzyme. (A) Superimposi-
tion of the WhiB1-bound ACTD and ACTD onto theM. tuberculosis RNAP–DNA complex (PDB ID: 6C04). The residues implicated in DNA binding
in WhiB1 and A4 are highlighted. (B) Detection of complex formation between WhiB1 and A in RNAP by size-exclusion chromatography. 3FLAG-
WhiB1 was detected by SDS PAGE (as indicated by the arrow) and western blot analysis using anti-FLAG M2 antibody (Sigma) in the peak fraction of
the sample containing the RNAP holoenzyme preincubated with 3FLAG-WhiB1, but not in the sample either containing the RNAP holoenzyme alone or
containing the RNAP core enzyme (without A) either or not preincubated with 3FLAG-WhiB1. (C) Cell growth curves ofM. smegmatis wildtype (WT)
and the whiB1 truncation mutant (WhiB1-ATD) without the C-terminal DNA binding motif, AT-hook, in 7H9 broth under optimal growth conditions.
(D) In vitro transcription from the rrnAP3 promoter in the absence and presence of the wildtype WhiB1 or the WhiB1-F17A mutant. Each 20-l reaction
contains the RNAP holoenzyme (250 nM), the rrnAP3DNA template (10 nM), and varying amounts of the wild-type WhiB1 or WhiB1-F17A mutant as
indicated. The reaction buffer contains 10 mM Tris-HCl, pH 8.0, 50 mM KCl, 10 mM MgCl2, 0.1 mM EDTA, 0.1 mM DTT, and 50 g/ml BSA. The
RNAP holoenzyme was pre-incubated with the WhiB1 proteins under anaerobic conditions before adding the rrnAP3 DNA template. The RNAP core
enzyme (250 nM) was used as a negative control (NC). The in vitro transcript products were separated on 8M-6% polyacrylamide gels, and the full gel
images are shown in Supplementary Figure S8.
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Figure 6. Proposed working model of holo-WhiB1 in transcriptional regulation via interaction with A4. (A) Diagram that demonstrates the CTD-
mediated transcription factor–independent activation by recognizing the up element (UP) of the target promoters. (B and C) Diagrams of the Class I
and Class II transcription activation, respectively. The 3D structures of the cyclic AMP receptor protein (CRP) bound RNAP–DNA complexes for the
CRP-dependent Class I and Class II transcription activation (PDB IDs: 3IYD and 5I2D, respectively) are used as models. (D and E) Diagrams of the
proposed working model for holo-WhiB1 in transcriptional regulation via interaction with A4. Panel D illustrates that WhiB1 binding to A4 can block
the binding site for activators or CTD, and thus repress transcription. Panel E shows that WhiB1 binding to A4 in RNAP, either alone or in concert with
a to-be-defined transcription regulator, may stabilize the interaction between RNAP and a specific subset of promoters, and thus activate transcription.
They stabilize the RNAP–DNA open complex inM. tuber-
culosis via interaction with RNAP (including regions 2 and
3 of A) and the fork-junction promoter DNA near the -
10 element with low sequence specificity (59–61). Consid-
ering the structure of WhiB1, we expect that holo-WhiB1
may have low DNA specificity like RbpA and CarD, if it
binds to DNA at all. This speculation is supported by our
observation that WhiB1 does not significantly enhance the
binding affinity of A to the whiB1 promoter in the EMSA
assays, and that the single DNA binding motif of WhiB1
is not required for its essential role in supporting mycobac-
terial growth. Although we cannot rule out the possibility
that A4–boundWhiB1 may recognize target gene promot-
ers other than whiB1 itself, such a case has not yet been
reported for a canonical Class II transcription activator in
bacteria. As a A4-bound transcription regulator, WhiB1 is
more likely to be involved in differentiation of gene expres-
sion by modulating the DNA binding preference of RNAP,
rather than facilitating the transition and stabilizing the
open state of theRNAP–DNAcomplex asRbpAandCarD
do.
A key finding in this report is the unusual hydrophobic
residue-driven interaction between WhiB1 and A4, which
induces conformational changes in both binding partners.
This distinguishes WhiB1 from other well-characterized
Class II transcription activators (i.e. CRP and FNR) that
bind directly to 704 (10,23). In the canonical Class II acti-
vation mechanism, transcription activators recognize and
bind to the target DNA sequence adjacent to the -35 el-
ement, and then recruit RNAP to the site for the initia-
tion of transcription via contact with 704 (Figure 6). Al-
though less common, there are examples of transcription
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activators, such as SoxS involved in redox stress response,
that can bind to 704 in RNAP without the presence of
target DNA via the pre-recruitment mechanism (27). In ei-
ther case, these transcription activators are in loose contact
with704 through surface charge complementarity, and typ-
ically do not induce conformational changes in either pro-
tein (11,12,21). The loose interaction with 704 is consistent
with the promoter-centered activation mechanism, which
requires rapid disassociation between the transcription ac-
tivator and RNAP upon initiation of transcription, and re-
lease of RNAP for recruitment by other 704–dependent
transcription factors. The hydrophobic residue-driven inter-
action between WhiB1 and A4, on the other hand, is in-
compatible with such a mechanism. Interestingly, a similar
interaction with 704 has been observed with the so-called
“phage appropriator” AsiA, a viral transcription regulator
from the bacteriophage T4 that remodels the DNA pref-
erence of host RNAP by a mechanism of  appropriation
(62,63). In this mechanism, AsiA binds tightly to 704 in E.
coli RNAP and induces conformational changes in 704 so
that it cannot recognize the –35 element of host genes; in-
stead the phage activatorMotAmakes use of the remodeled
704 in host RNAP to express genes in the middle stage of
the phage T4 life cycle.
Besides the A4–bound transcription activators, the in-
teraction interface of WhiB1 and A also overlaps with
CTD in RNAP. In bacteria, CTD not only binds to the
UP elements for transcription factor–independent activa-
tion of many promoters, but also plays a major role in tran-
scriptional regulation through interaction with Class I and
Class II transcription factors (Figure 6A-C) (64–66). The
effect of WhiB1 on in vitro transcription that we observe
aligns with previous studies on the 3D structure of RNAP
and sequence analysis of potential UP elements in promot-
ers in M. tuberculosis (55), suggesting that CTD may play
a similar role in transcriptional regulation in mycobacteria
as reported in E. coli and other bacteria. How the interac-
tion between WhiB1 and A influences the functional role
of CTD and A4–bound transcription activators warrants
further investigation.
Considering all the evidence together, we propose that
holo-WhiB1 regulates gene expression by modulating the
promoter recognition preference of RNAP during tran-
scription initiation (Figure 6D and E). This working model
accounts for our observation of an unusual hydrophobic
residue-driven interaction between holo-WhiB1 and A4
and high levels of expression of WhiB1 relative to A inM.
tuberculosis, as reported previously (5). On one hand, owing
to its tight interaction with A4, it is plausible that WhiB1
could block Class II transcription activators and/or CTD
from binding to A4, thus suppressing expression of genes
regulated by these transcription activators and/or CTD if
at high cellular levels (Figure 6D). We have experimentally
demonstrated that WhiB1 can interact with A to repress
transcription from rrnAP3 in vitro. Moreover, it has been
reported that under-expression of whiB1 inM. tuberculosis
caused more genes to be up-regulated than down-regulated
(20 versus 3) in a comparative transcriptomic experiment
(8). Our model is also consistent with the previous report
that WhiB1 was post-translationally regulated by the Clp
protease, and disruption of the WhiB1 degradation by the
Clp protease inhibited cell growth in M. tuberculosis (67).
On the other hand, our site-directed mutagenesis of whiB1
in M. smegmatis suggests that the interaction with A4 is
required for the essential role of WhiB1 in supporting my-
cobacterial growth. This may imply that the interaction be-
tweenWhiB1 andA4 is required for the activation of essen-
tial genes, either alone or in concert with other regulators or
CTD (Figure 6E). Candidate genes for this mode of regula-
tion include the essential gene encoding salicylate synthase,
mbtI, which was down-regulated with under-expression of
WhiB1 inM. tuberculosis (8,68).
Although the proposed working model of holo-WhiB1 is
unprecedented among the A4–bound bacterial transcrip-
tion factors, it closely resembles the mode of action of Spx,
a global regulator that is responsive to heat and oxidative
stress in Bacillus subtilis (69–71). Similar to holo-WhiB1,
Spx is a monomeric transcription factor without known
DNA binding capacity (57). It was first characterized as
an anti- factor because Spx was found to bind to CTD
of RNAP and interfere with CTD-dependent transcription
of genes (57,72,73). Subsequently, it was reported that Spx
also activate redox stress response genes and its interaction
with CTD is required for transcription activation (73,74).
Like WhiB1, Spx is also regulated by the Clp protease (75),
presumably to balance its dual activities.
In summary, our results indicate that holo-WhiB1 is
a non-canonical transcription factor that interacts with
A4 using a newly characterized interface dominated by
hydrophobic contacts and represses transcription from
rrnAP3 in vitro, distinguishing it from previously character-
ized 704-dependent transcription activators (7,11,12). The
interaction with A4 also renders the Fe–S cluster inWhiB1
remarkably stable to O2, which is needed for NO sens-
ing in aerobic bacteria. Future investigations of the genetic
and functional aspects of WhiB1 and the structural char-
acterization of WhiB1 interaction with the RNAP holoen-
zymewill further advance themechanistic understanding of
WhiB1 in NO sensing and transcriptional regulation inM.
tuberculosis.
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